Stable benefit of embryonic stem cell therapy in myocardial infarction

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 287, Issue 2 56-2, 2004, Pages

  Hodgson, Denice M ^a   Behfar, Atta ^a   Zingman, Leonid V ^a   Kane, Garvan C ^a   Perez Terzic, Carmen ^a   Alekseev, Alexey E ^a   Pucéat, Michel ^a,b   Terzic, Andre ^a,c  

^a Mayo Clinic   (United States)

^b Centre National de la Recherche Scientifique   (France)

^c MAYO CLINIC   (United States)

Author keywords

Cardiac differentiation; Engraftment; Heart; Plasticity; Remodeling; Xenotransplant

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL REGENERATION; CONTROLLED STUDY; DRUG RESPONSE; EMBRYO CELL; FOLLOW UP; HEART DEVELOPMENT; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE REMODELING; INOTROPISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCAR; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CICATRIX; CRICETINAE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; RATS; REGENERATION; STEM CELL TRANSPLANTATION; STEM CELLS; VENTRICULAR REMODELING;

EID: 3242677045     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.01247.2003     Document Type: Article

References (47)

1. Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, Zeiher AM, and Dimmeler S. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 9: 1370-1376, 2003.
2. Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, Rovner A, Ellis SG, Thomas JD, DiCorleto PE, Topol EJ, and Penn MS. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362: 697-703, 2003.
3. Behfar A, Zingman LV, Hodgson DM, Rauzier J, Kane GC, Terzic A, and Puceat M. Stem cell differentiation requires a paracrine pathway in the heart. FASEB J 16: 1558-1566, 2002.
4. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B, and Anversa P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114: 763-776, 2003.
5. Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R, Nadal-Ginard B, Silvestri F, Leri A, Beltrami CA, and Anversa P. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 344: 1750-1757, 2001.
6. Boheler KR, Czyz J, Tweedie D, Yang HT, Anisimov SV, and Wobus AM. Differentiation of pluripotent embryonic stem cells into cardiomyocytes. Circ Res 91: 189-201, 2002.
7. Braunwald E and Bristow MR. Congestive heart failure: fifty years of progress. Circulation 102: IV14-IV23, 2000.
8. Britten MB, Abolmaali ND, Assmus B, Lehmann R, Honold J, Schmitt J, Vogl TJ, Martin H, Schachinger V, Dimmeler S, and Zeiher AM. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 108: 2212-2218, 2003.
9. Drukker M, Katz G, Urvach A, Schuldiner M, Markel G, Itskovitz-Eldor J, Reubinoff B, Mandelboim O, and Benvenisty N. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci USA 99: 9864-9869, 2002.
10. Erdo F, Buhrle C, Blunk J, Hoehn M, Xia Y, Fleischmann B, Focking M, Kustermann E, Kolossov E, Hescheler J, Hossmann KA, and Trapp T. Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke. J Cereb Blood Flow Metab 23: 780-785, 2003.
11. Frandrich F, Lin X, Chai GX, Schulze M, Ganten D, Bader M, Holle J, Huang DG, Parwaresch R, Zavazava N, and Binas B. Preimplantation-stage stem cells induce long-term allogenic graft acceptance without supplementary host conditioning. Nat Med 8: 171-178, 2002.
12. Gepstein L. Derivation and potential applications of human embryonic stem cells. Circ Res 91: 866-876, 2002.
13. He JQ, Ma Y, Lee Y, Thomson JA, and Kamp TJ. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res 93: 32-39, 2003.
14. ATP channel-dependent stress tolerance. EMBO J 22: 1732-1742, 2003.
15. Hubner K, Fuhrmann G, Christenson LK, Kehler J, Reinhold R, De La Fuente R, Wood J, Strauss JF, Boiani M, and Scholer HR. Derivation of oocytes from mouse embryonic stem cells. Science 300: 1251-1256, 2003.
16. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Jacobs AK, Hiratzka LF, Russell RO, and Smith SC Jr. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult. Circulation 104: 2996-3007, 2001.
17. Levenberg S, Golub JS, Amit M, Itskovitz-Eldor J, and Langer R. Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 99: 4391-4396, 2002.
18. Lila N, Amrein C, Guillemain R, Chevalier P, Latremouille C, Fabiani JN, Dausset J, Carosella ED, and Carpentier A. Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 105: 1949-1954, 2002.
19. Lin Q, Schwarz J, Bucana C, and Olson EN. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276: 1404-1407, 1997.
20. Maltsev VA, Wobus AM, Rohwedel J, Bader M, and Hescheler J. Cardiomyocytes differentiated in vitro from embryonic stem cells developmentally express cardiac-specific genes and ionic currents. Circ Res 75: 233-244, 1994.
21. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, and Dzau VJ. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts, Nat Med 9: 1195-2001, 2003.
22. Menasche P, Hagege AA, Vilquin JT, Desnos M, Abergel E, Pouzet B, Bel A, Sarateanu S, Scorsin M, Schwartz K, Bruneval P, Benbunan M, Marolleau JP, and Duboc D. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41: 1078-1083, 2003.
23. Mery A, Papadimou E, Zeineddine D, Menard C, Behfar A, Zingman LV, Hodgson DM, Rauzier JM, Kane GC, Perez-Terzic C, Terzic A, and Puceat M. Commitment of embryonic stem cells toward a cardiac lineage: molecular mechanisms and evidence for a promising therapeutic approach for heart failure. J Muscle Res Cell Motil 24: 269-274, 2003.
24. Meyer N, Jaconi M, Landopoulou A, Fort P, and Puceat M. A fluorescent reporter gene as a marker for ventricular specification in ES-derived cardiac cells. FEBS Lett 478: 151-158, 2000.
25. Min J, Yang Y, Converso KL, Liu L, Huang Q, Morgan JP, and Xiao Y. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J Appl Physiol 92: 288-296, 2002.
26. Min J, Yang Y, Sullivan MF, Ke Q, Converso KL, Chen Y, Morgan JP, and Xiao Y. Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. J Thorac Cardiovasc Surg 125: 361-369, 2003.
27. Murry CE, Whitney ML, Laflamme MA, Reinecke H, and Field LJ. Cellular therapies for myocardial infarct repair. Cold Spring Harb Symp Quant Biol 67: 519-526, 2002.
28. Nir SG, David R, Zaruba M, Franz WM, and Itskovitz-Eldor J. Human embryonic stem cells for cardiovascular repair. Cardiovasc Res 58: 313-323, 2003.
29. Oh H, Bradfute SB, Gallardo TD, Nakamura T, Gaussin V, Mishina Y, Pocius J, Michael LH, Behringer RR, Garry DJ, Entman ML, and Schneider MD. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 100: 12313-12318, 2003.
30. Olson EN and Schneider MD. Sizing up the heart: development redux in disease. Genes Dev 17: 1937-1956, 2003.
31. Orlic D, Hill JM, and Arai AE. Stem cells for myocardial regeneration. Circ Res 91: 1092-1102, 2002.
32. Perez-Terzic C, Behfar A, Mery A, van Deursen JM, Terzic A, and Puceat M. Structural adaptation of the nuclear pore complex in stem cell-derived cardiomyocytes. Circ Res 92: 444-452, 2003.
33. Perez-Terzic C, Gacy AM, Bortolon R, Dzeja PP, Puceat M, Jaconi M, Prendergast FG, and Terzic A. Directed inhibition of nuclear import in cellular hypertrophy. J Biol Chem 276: 20566-20571, 2001.
34. Sachinidis A, Fleischmann BK, Kolossov E, Wartenberg M, Sauer H, and Hescheler J. Cardiac specific differentiation of mouse embryonic stem cells. Cardiovasc Res 58: 278-291, 2003.
35. Smith AG. Embryo-derived stem cells: of mice and men. Annu Rev Cell Dev Biol 17: 435-462, 2001.
36. Solloway MJ and Harvey RP. Molecular pathways in myocardial development: a stem cell perspective. Cardiovasc Res 58: 264-277, 2003.
37. Thompson RB, Emani SM, Davis BH, van den Bos EJ, Morimoto Y, Craig D, Glower D, and Taylor DA. Comparison of intracardiac cell transplantation: autologous skeletal myoblasts versus bone marrow cells. Circulation 108: II264-II271, 2003.
38. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, and Jones JM. Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147, 1998.
39. Towbin JA and Bowles NE. The failing heart. Nature 415: 227-233, 2002.
40. Tzukerman M, Rosenberg T, Ravel Y, Reiter I, Coleman R, and Skorecki K. An experimental platform for studying growth and invasiveness of tumor cells within teratomas derived from human embryonic stem cells. Proc Natl Acad Sci USA 100: 13507-13512, 2003.
41. Vassilopoulos G, Wang PR, and Russell DW. Transplanted bone marrow regenerates liver by cell fusion. Nature 422: 901-904, 2003.
42. Verfaillie CM. Adult stem cells: assessing the case for pluripotency. Trends Cell Biol 12: 502-508, 2002.
43. Wang X, Willenbring H, Akkari Y, Torimaru Y, Foster M, Al-Dhalimy M, Lagasse E, Finegold M, Olson S, and Grompe M. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 422: 897-901, 2003.
44. Yang Y, Min J, Rana JS, Ke Q, Cai J, Chen Y, Morgan JP, and Xiao Y. VEGF enhances functional improvement of postinfarcted hearts by transplantation of ECS-differentiated cells. J Appl Physiol 93: 1140-1151, 2002.
45. Ying QL, Nichols J, Chambers I, and Smith A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115: 281-292, 2003.
46. Zingman LV, Hodgson DM, Bast PH, Kane GC, Perez-Terzic C, Gumina RJ, Pucar D, Bienengraeber M, Dzeja PP, Miki T, Seino S, Alekseev AE, and Terzic A. Kir6.2 is required for adaptation to stress. Proc Natl Acad Sci USA 99: 13278-13283, 2002.
47. + channels. J Biol Chem 277: 14206-14210, 2002.